Medanta IPO GMP History
Medanta IPO has been listed on November 16, 2022 at a listing price of ₹401, against the issue price of ₹336 — a gain of ₹65 (+19.35%). The GMP peaked at ₹28 on 3 November 2022 and reached a low of ₹12 on 11 November 2022. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Medanta IPO raised ₹2205.57 Cr. through its IPO at a price band of ₹319 to ₹336 per share, with a lot size of 44 shares. The IPO was open for subscription from 03 Nov 2022 to 07 Nov 2022.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 10 Nov, 11:32 AM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 15 Nov 2022 | ₹ 20 | — | 6% | — | — |
| 14 Nov 2022 | ₹ 20 | ▲ | 6% | — | — |
| 12 Nov 2022 | ₹ 18 | ▲ | 5% | — | — |
| 11 Nov 2022 | ₹ 12 | — | 4% | — | — |
| 10 Nov 2022 | ₹ 12 | ▼ | 4% | — | — |
| 09 Nov 2022 | ₹ 15 | — | 4% | — | — |
| 08 Nov 2022 | ₹ 15 | ▼ | 4% | — | — |
| 07 Nov 2022 | ₹ 18 | ▼ | 5% | — | — |
| 04 Nov 2022 | ₹ 20 | ▼ | 6% | — | — |
| 03 Nov 2022 | ₹ 28 | ▲ | 8% | — | — |
| 02 Nov 2022 | ₹ 25 | ▲ | 7% | — | — |
| 01 Nov 2022 | ₹ 20 | — | 6% | — | — |
| 31 Oct 2022 | ₹ 20 | ▲ | 6% | — | — |
| 29 Oct 2022 | ₹ 15 | ▼ | 4% | — | — |
| 28 Oct 2022 | ₹ 20 | — | 6% | — | — |
Medanta IPO dates
Key dates from opening to listing. Today is 10 November.
- Open 03 Nov 2022
- Close 07 Nov 2022
- Allotment 11 Nov 2022
- Refund/credit 14 Nov 2022
- Listing 16 Nov 2022
Medanta IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹336 |
|---|---|
| GMP-based estimate (pre-listing) | ₹356 (+6%) |
| Listing gain / loss | +₹65 per share |
| Listing date | 16 Nov, 2022 |
| Actual listing price | ₹401 (+19.35%) |
Is Medanta IPO GMP reliable?
Grey market premium for Medanta IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Medanta IPO full review for a fundamentals-based assessment before making any grey market trades.
Medanta IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Medanta IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Medanta IPO
Global Health Limited was incorporated as Global Health Private Limited at New Delhi on 13 August 2004. It is one of the largest private multi-specialty tertiary care providers in North and East India, under the Medanta brand.
Its key specialties are cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology. It set up the Medanta Institutional Tissue Repository in 2017 for biomarker and tissue-based research.
It runs four hospitals at Gurugram, Indore, Ranchi and Lucknow. Its business was materially hit by the pandemic in Fiscal 2021. The promoter is Dr. Naresh Trehan.
The IPO was Rs 2,205.57 crore, with Rs 500.00 crore of fresh issue and Rs 1,705.57 crore of offer for sale. Rs 375.00 crore was planned for helping two subsidiaries repay borrowings.
Frequently asked
What is the GMP of Medanta IPO?
The current Grey Market Premium (GMP) of Medanta IPO is ₹ 20.
What is the Kostak Price of Medanta IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Medanta IPO is not available.
What is the Subject to Sauda Price of Medanta IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Medanta IPO?
Medanta IPO listed on November 16, 2022 at ₹401, against the issue price of ₹336 — a gain of +19.35%.
How did the GMP of Medanta IPO trend before listing?
The GMP of Medanta IPO was stable in its final days before listing. The GMP peaked at ₹28 on 3 November 2022. View the day-wise table above for the complete GMP history.
Explore Medanta IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
